CONMED
CNMD
207 hedge funds and large institutions have $1.75B invested in CONMED in 2018 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 80 increasing their positions, 52 reducing their positions, and 39 closing their positions.
54% more repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 52
0% more funds holding
Funds holding: 207 → 207 (0)
0% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 39
1.16% less ownership
Funds ownership: 97.92% → 96.76% (-1.2%)
20% less capital invested
Capital invested by funds: $2.18B → $1.75B (-$433M)
21% less call options, than puts
Call options by funds: $712K | Put options by funds: $899K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$16.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$11M |
| 4 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$7.35M |
| 5 |
Millennium Management
New York
|
+$6.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
-$16.1M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$15.7M |
| 3 |
Morgan Stanley
New York
|
-$13.9M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$13.5M |
| 5 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$12.2M |
CNMD Hedge Fund Activity: Q4 2018 in Review
207 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q4 2018, worth a combined $1.75B — down 20% from $2.18B a quarter earlier.
Fund positioning in CNMD was balanced in Q4 2018: 39 funds opened new positions, 39 closed out, 80 added to existing stakes and 52 trimmed.
The largest buyer was BlackRock, adding an estimated $16.3M. The largest seller was Scopia Capital Management, cutting an estimated $16.1M.
- 207 institutional investors held CONMED (CNMD) as of Q4 2018, unchanged from Q3 2018.
- Funds reported $1.75B of CONMED stock for Q4 2018, down 20% quarter-over-quarter.
- 39 funds opened new CONMED positions in Q4 2018 and 39 closed out, a net change of 0 holders.
- The largest CONMED buyer in Q4 2018 was BlackRock, an estimated $16.3M added.
- The largest CONMED seller in Q4 2018 was Scopia Capital Management, an estimated $16.1M sold.
Based on aggregated 13F filings for Q4 2018.